Avanos Medical, Inc.

No listen-only mode. Should you need assistance at any time, please press star zero to signal an operator. After today's prepared remarks, there will be an opportunity to ask questions. To ask a question, you may press star, then one on your telephone keypad, and to withdraw your question, you may press star, then two. Please note, today's call is being recorded. At this time, I'd like to hand the floor over to Avanos CEO, Joe Woody.

Good morning, everyone. This is Joe Woody. We've asked the New York Stock Exchange, and they agreed to halt our trading as our results were inaccurately reported by one news outlet and possibly more. Our total results, inclusive of respiratory health, were 199.8 million in revenue, and we delivered 37 cents of EPS. Throughout the day today, we're going to work with the various agencies and news outlets to correct the information. Now I'm going to turn the call over to Scott Galvin to begin our prepared remarks. Thank you.

Good morning, everyone, and thanks for joining us. It's my pleasure to welcome you to Avano's 2023 Second Quarter Earnings Conference Call. Presenting today will be Joe Woody, CEO, and Michael Greiner, Senior Vice President, CFO, and Chief Transformation Officer. Joe will review our second quarter and expectations for the remainder of 2023 as well as provide further insights around the strategy we laid out at our investor day in June. Michael will provide additional detail regarding these topics and provide an update of our 2023 planning assumptions given our respiratory health business discontinued operations. We'll finish the call with Q&A. A presentation for today's call is available on the investor section of our website, avanos.com. As a reminder, our comments today contain forward-looking statements related to the company, our expected performance, current economic conditions, and our industry. No assurance can be given as to future financial results. Actual results could differ materially from those in the forward-looking statements. For more information about forward-looking statements and the risk factors that could influence future results, please see today's press release and risk factors described in our filings with the SEC. Additionally, we will be referring to adjusted results and outlook. The press release has information on these adjustments and reconciliations to comparable GAAP financial measures. Now, I'll turn the call over to Joe.